BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million
Reuters
Aug 29
BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million
Aug 29 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:
H1 GROSS PROFIT RMB 757.3 MILLION
H1 GROSS MARGIN 66.1%
H1 PRETAX PROFIT RMB 156.9 MILLION
H1 REVENUE RMB 1,146.2 MILLION
H1 OPERATING PROFIT RMB 264.4 MILLION
RESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHARE
Further company coverage: 0460.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.